Exact Mass: 443.218196
Exact Mass Matches: 443.218196
Found 100 metabolites which its exact mass value is equals to given mass value 443.218196
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lanraplenib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
plumbagine F alpha-D-xylopyranoside|plumbagoside C
C20H33N3O8 (443.22675380000004)
Ala Ala Pro Trp
C22H29N5O5 (443.21685840000004)
Ala Ala Trp Pro
C22H29N5O5 (443.21685840000004)
Ala Pro Ala Trp
C22H29N5O5 (443.21685840000004)
Ala Pro Trp Ala
C22H29N5O5 (443.21685840000004)
Ala Trp Ala Pro
C22H29N5O5 (443.21685840000004)
Ala Trp Pro Ala
C22H29N5O5 (443.21685840000004)
Cys Lys Pro Pro
C19H33N5O5S (443.2202288000001)
Cys Pro Lys Pro
C19H33N5O5S (443.2202288000001)
Cys Pro Pro Lys
C19H33N5O5S (443.2202288000001)
Asp Gly Pro Arg
Asp Gly Arg Pro
Asp Pro Gly Arg
Asp Pro Arg Gly
Asp Arg Gly Pro
Asp Arg Pro Gly
Gly Asp Pro Arg
Gly Asp Arg Pro
Gly Pro Asp Arg
Gly Pro Arg Asp
Gly Arg Asp Pro
Gly Arg Pro Asp
Lys Cys Pro Pro
C19H33N5O5S (443.2202288000001)
Lys Pro Cys Pro
C19H33N5O5S (443.2202288000001)
Lys Pro Pro Cys
C19H33N5O5S (443.2202288000001)
Pro Ala Ala Trp
C22H29N5O5 (443.21685840000004)
Pro Ala Trp Ala
C22H29N5O5 (443.21685840000004)
Pro Cys Lys Pro
C19H33N5O5S (443.2202288000001)
Pro Cys Pro Lys
C19H33N5O5S (443.2202288000001)
Pro Asp Gly Arg
Pro Asp Arg Gly
Pro Gly Asp Arg
Pro Gly Arg Asp
Pro Lys Cys Pro
C19H33N5O5S (443.2202288000001)
Pro Lys Pro Cys
C19H33N5O5S (443.2202288000001)
Pro Pro Cys Lys
C19H33N5O5S (443.2202288000001)
Pro Pro Lys Cys
C19H33N5O5S (443.2202288000001)
Pro Arg Asp Gly
Pro Arg Gly Asp
Pro Trp Ala Ala
C22H29N5O5 (443.21685840000004)
Arg Asp Gly Pro
Arg Asp Pro Gly
Arg Gly Asp Pro
Arg Gly Pro Asp
Arg Pro Asp Gly
Arg Pro Gly Asp
Trp Ala Ala Pro
C22H29N5O5 (443.21685840000004)
Trp Ala Pro Ala
C22H29N5O5 (443.21685840000004)
Trp Pro Ala Ala
C22H29N5O5 (443.21685840000004)
N,N-Di-Boc-L-lysine hydroxysuccinimide ester
C20H33N3O8 (443.22675380000004)
(S)-2-(BENZYLOXYCARBONYLAMINO)-3-BUTENOICACIDMETHYLESTER
C24H33NO5Si (443.21278880000006)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-ethylphenyl)-N-(3-pyridinylmethyl)- (9CI)
C26H29N5S (443.21435540000004)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2,5-dimethylphenyl)-N-(3-pyridinylmethyl)- (9CI)
C26H29N5S (443.21435540000004)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2,4-dimethylphenyl)-N-(3-pyridinylmethyl)- (9CI)
C26H29N5S (443.21435540000004)
Levorphanol tartrate (powder)
C21H33NO9 (443.21552080000004)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
2-(3,5-Dimethylphenoxy)-4-[1-(piperidine-4-yl)-4-(4-fluorophenyl)-5-imidazolyl]pyrimidine
2-[8-(2-Naphthalenylmethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]acetic acid methyl ester
C27H29N3O3 (443.22088040000006)
2-[4-Methoxy-3-(4-morpholinylmethyl)phenyl]-3-(phenylmethyl)-1,2-dihydroquinazolin-4-one
C27H29N3O3 (443.22088040000006)
7-[2-Hydroxy-3-(4-methoxyphenoxy)propyl]-1,3-dimethyl-8-(1-piperidinyl)purine-2,6-dione
C22H29N5O5 (443.21685840000004)
1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2,5-dimethylphenyl)-1-(3-pyridinylmethyl)thiourea
C26H29N5S (443.21435540000004)
1-[(3aS,4R,9bR)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-pyridin-4-ylethanone
C27H29N3O3 (443.22088040000006)
2-fluoro-N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(1S,9R,10R,11R)-5-(4-fluorophenyl)-10-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
2-fluoro-N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
2-fluoro-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
4-fluoro-N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
3-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(1R,9S,10S,11S)-5-(4-fluorophenyl)-10-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H29N3O3 (443.22088040000006)
4-[4-[(6R,7R,8S)-4-[cyclohexyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile
C27H29N3O3 (443.22088040000006)
4-[4-[(6R,7R,8R)-4-[cyclohexyl(oxo)methyl]-8-(hydroxymethyl)-2-oxo-1,4-diazabicyclo[4.2.0]octan-7-yl]phenyl]benzonitrile
C27H29N3O3 (443.22088040000006)
NNC 63-0532
C27H29N3O3 (443.22088040000006)
NNC63-0532 is a novel non-peptide nociceptin receptor (ORL1) agonist, with EC50s of 305?nM. NNC63-0532 plays important roles in many disorders such as pain, drug addiction[1].